Circulogene launches new liquid biopsy test for cancer
Alabama startup CirculoGene Theranostics has released a new liquid biopsy test for cancer monitoring - but will it stick?
Alabama startup CirculoGene Theranostics has released a new liquid biopsy test for cancer monitoring - but will it stick?
Personalized medicine player Theranostics is in the midst of a modest fund raise – it’s raising $1 million in equity, according to a regulatory filing. Not to be confused with biotech media darling Theranos – the Bay Area startup that means to do a wide range of testing form a single blood drop – Theranostics still […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.